 Allergan Inc. has filed a federal lawsuit challenging the legality of Valeant Pharmaceuticals International Inc.'s joint takeover bid with investor William Ackman, saying their pursuit of the company violated securities laws meant to prevent investors from profiting from inside information.. Valeant and Mr. Ackman's Pershing Square Capital Management LP are both defendants in the suit. They unveiled their bid in April after Pershing Square bought about 9.7% of Allergan. After being rebuffed by Allergan's board, they launched...
  